0001127602-17-010543.txt : 20170307
0001127602-17-010543.hdr.sgml : 20170307
20170307153313
ACCESSION NUMBER: 0001127602-17-010543
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170306
FILED AS OF DATE: 20170307
DATE AS OF CHANGE: 20170307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edge Therapeutics, Inc.
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOUGHLIN JAMES J
CENTRAL INDEX KEY: 0001276550
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 17671780
MAIL ADDRESS:
STREET 1: DORSEY & WHITNEY LLP
STREET 2: 250 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10177
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-03-06
0001472091
Edge Therapeutics, Inc.
EDGE
0001276550
LOUGHLIN JAMES J
300 CONNELL DRIVE, SUITE 4000
BERKELEY HEIGHTS
NJ
07922
1
Common Stock
2017-03-06
4
P
0
3000
9.24
A
6000
I
Family Trust
Common Stock
19625
D
The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ James J. Loughlin by Albert N. Marchio II, attorney-in-fact
2017-03-07